CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Hamps Bio Ltd.

NSE : BSE : 544312 ISIN CODE : INE0QBD01018Industry : Pharmaceuticals

News

  • Hamps Bio - Announcement under Regulation 30 (LODR)-Updates on Acquisition 25 Mar 2026 | 16:43 | Dion Global

    Update on Acquistion of 100% equity shares of HSDL Innovative Private Limited. This is to inform you that the Company has completed acquisition of 10...more...

  • Hamps Bio - Considered And Approved The Acquisition Of 100% Of Paid-Up Equity Share Capital Of HSDL Innovative Private Limite 14 Feb 2026 | 17:36 | Dion Global

    Considered and approved the acquisition of 100% of paid-up equity share capital of HSDL Innovative Private Limited.more...

  • Hamps Bio - Board Meeting Outcome for Considered And Approved The Acquisition Of 100% Of Paid-Up Equity Share Capital Of HSDL 14 Feb 2026 | 17:27 | Dion Global

    Considered and approved the acquisition of 100% of paid-up equity share capital of HSDL Innovative Private Limited.more...

  • Hamps Bio - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 16 Jan 2026 | 11:22 | Dion Global

    The certificate under regulation 74(5) of SEBI (DP) Regulatons 2018 is attached herewith.more...

  • Hamps Bio - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report 25 Nov 2025 | 18:09 | Dion Global

    We have attached herewith the Scrutinizer s Report.\r\nKindly take the same on your record.more...

  • Hamps Bio - Shareholder Meeting / Postal Ballot-Outcome of EGM 24 Nov 2025 | 18:36 | Dion Global

    Enclosed herewith is the outcome of EGM of the company held on Monday 24th November 2025 at the corporate office of the company.more...

  • Hamps Bio - Unaudited Financial Results For The Half Year Ended 30.09.2025. 14 Nov 2025 | 19:26 | Dion Global

    Unaudited Financial Results for the Half Year Ended 30.09.2025 is attached herewith.more...

  • Hamps Bio - Board Meeting Outcome for Board Meeting Outcome For Approval Of Unaudited Financial Results For The Half Year End 14 Nov 2025 | 19:14 | Dion Global

    The Unaudited Financial Results for the half year ended on 30.09.2025 is attached herewith for your reference.more...

  • Hamps Bio - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Half Year Ended Se 13 Nov 2025 | 19:20 | Dion Global

    Hamps Bio Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve...more...

  • Hamps Bio - Intimation For Re-Scheduling The Date Of The Board Meeting. 13 Nov 2025 | 15:57 | Dion Global

    Intimation for re-scheduling the date of the Board Meeting is attached herewith.more...

  • Hamps Bio - Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Half Year Ended September 30, 20 06 Nov 2025 | 18:42 | Dion Global

    Hamps Bio Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve...more...

  • Hamps Bio - Notice Of Extra Ordinary General Meeting Of The Shareholders Of The Company Scheduled To Be Held On 24Th November 01 Nov 2025 | 15:47 | Dion Global

    We hereby submit the Notice of Extra Ordinary General Meeting.more...

  • Hamps Bio - Announcement For Calling Extra Ordinary General Meeting Of The Company 31 Oct 2025 | 18:31 | Dion Global

    Announcement for calling Extra Ordinary General Meeting of the company is attached herewith.more...

  • Hamps Bio has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025 17 Oct 2025 | 17:30 | Dion Global

    As of September 2025 72.00% is owned by Indian Promoters and 28.01% by Public. Top five Promoters holding highest number of shares of Hamps ...more...

  • Hamps Bio - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 14 Oct 2025 | 17:18 | Dion Global

    The Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 is attached herewith.more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex71947.55-2.22%
NSE Index22331.4-2.13%
B500DIVL503331.35-1.00%
BSE 1000 9533.77-2.32%
BSE 100LCTMC8270.37-2.19%
BSE Auto 52613.98-2.33%

Commodity

Gold1461262.66%
Silver2288603.22%
Copper1170.85187.11%
Crude Oil942646.98%
Lead197.1546.69%
Mentha Oil1121.65.08%
Nickel1636.6113.40%

Currency

USD/INR 94.60(0.67 %)
GBP/INR 126.20(0.34 %)
EUR/INR 109.16(0.19 %)
JPY/INR 0.59(-0.16 %)
CAD/INR 68.24(0.00 %)
HKD/INR 11.99(-0.02 %)